Fig. 8

AS-clinic nomograms for predicting the individualized survival rates of TNBC patients for two aspects of OS and PFS. a, e Construction of AS-clinic nomograms for TNBC patients to predict 2, 3, and 4 year OS (a) and PFS (e), which were incorporated with 3 variables, including risk, AJCC and radiotherapy. b–d, f–h Calibration plots of the AS-clinic nomograms in terms of agreement between nomogram-predicted and observed 2, 3, and 4 year outcomes of the TNBC cohort, including OS (b–d) and PFS (f–h). The 45º dashed line represents the ideal performance. The actual performances of the model are represented by the red lines, and the figures from left to right show the 2, 3, and 4 year results